Advanced search
Publication Cover
Stem Cells and Cloning: Advances and Applications Volume 12, 2019 - Issue
Submit an article Journal homepage
94
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Stem-cell therapy for ovariectomy-induced osteoporosis in rats: a comparison of three treatment modalities

Mir Sadat-Ali1 Department of Orthopaedic SurgeryCorrespondence[email protected]
,
Dakheel A Al-Dakheel1 Department of Orthopaedic Surgery
,
Sulaiman A AlMousa1 Department of Orthopaedic Surgery
,
Fawaz M AlAnii1 Department of Orthopaedic Surgery
,
Waleed Y Ebrahim1 Department of Orthopaedic Surgery
,
Hussain K AlOmar1 Department of Orthopaedic Surgery
,
Hasan N AlSayed1 Department of Orthopaedic Surgery
,
Sadananda Acharya2 College of Public Health
&
Hussain AlHawaj3 Institute of Research and Medical Consultations, Imam Abdul Rahman Bin Faisal University, Dammam, Saudi Arabia
 show all
Pages 17-25 | Published online: 14 Jun 2019

References

  • Sadat-Ali M, Al-Turki HA, Acharya S, Al-Dakheel DA. Bone marrow-derived osteoblasts in the management of ovariectomy induced osteoporosis in rats. J Stem Cells Regen Med. 2018;14(2):1–6.30018467
  • Kiernan J, Hu S, Grynpas MD, Davies JE, Stanford WL. Systemic mesenchymal stromal cell transplantation prevents functional bone loss in a mouse model of age-related osteoporosis. Stem Cells Transl Med. 2016;5(5):683–693. doi:10.5966/sctm.2015-023126987353
  • Piao H, Youn T-J, Kwon J-S, et al. Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infarcting myocardium. Eur J Heart Fail. 2005;7(5):730–738.16158494
  • Ge M, Ke R, Cai T, Yang J, Mu X. Identification and proteomic analysis of osteoblast-derived exosomes. Biochem Biophys Res Commun. 2015;467(1):27–32. doi:10.1016/j.bbrc.2015.09.13526420226
  • Chopra A. Osteoporosis: A new understanding of its impact and pathogenesis. J Am Osteopath Assoc. 2000;100(1 suppl):S1–4.
  • Sadat-Ali M, Al-Dakheel DA, Azam MQ, et al. Reassessment of osteoporosis-related femoral fractures and economic burden in Saudi Arabia. Arch Osteoporos. 2015;10:37 PMID:26494131 10.1007/s11657-015-0240-526494131
  • Graham DY. What the gastroenterologists should know about the gastrointestinal safety profiles of bisphosphonates. Dig Dis Sci. 2002;47:1665–1678.12184516
  • de Groen PC, Lubbe DF, Hirsch LJ, et al. Esophagitis associated with the use of alendronate. N Engl J Med. 1996;335:1016–1021. doi:10.1056/NEJM1996100333514038793925
  • Rupel K, Ottaviani G, Gobbo M, et al. A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncol. 2014;50:1049–1057; pii:S1368-8375(14)00250-4 10.1016/j.oraloncology.2014.08.01625240948
  • Holzinger D, Seemann R, Matoni N, Ewers R, Millesi W, Wutzl A. Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2014;72(10):1937.e1-8 10.1016/j.joms.2014.04.037 Epub 2014 May 24.
  • Kharazmi M, Hallberg P. Bisphosphonate-associated atypical femoral fractures and one-year mortality. Ups J Med Sci. 2014;119(4):357–358.
  • Bhadada SK, Sridhar S, Muthukrishnan J, et al. Predictors of atypical femoral fractures during long term bisphosphonate therapy: A case series & review of literature. Indian J Med Res. 2014;140(1):46–54.25222777
  • Thompson D. On Growth and Form. New York, NY: Macmillan Co.; 1945:1116.
  • Hernlund E, Svedbom A, Ivergård M, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8:136. doi:10.1007/s11657-013-0136-124113837
  • Burge R, Dawson-Hughes B, Solomon D, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22(3):465–475. doi:10.1359/jbmr.06111317144789
  • Si L, Winzenberg TM, Jiang Q, Chen M, Palmer AJ. Projection of osteoporosis-related fractures and costs in China: 2010–2050. Osteoporos Int. 2015;26:1929–1937.25761729
  • Medscape. FDA rejects romosozumab for osteoporosis, wants more data. 7 17, 2017 Available at: www.medscape.com/view-article/882966. Accessed 1111, 2018.
  • Mullard A. Merck & Co. drops osteoporosis drug odanacatib. Nat Rev Drug Discov. 2016;15(10):669–671.
  • Camacho PM, Petak SM, Binkley N, et al. American association of clinical endocrinologists and American College of Endocrinology: clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2016;22(suppl 4):S1–S42. doi:10.4158/1934-2403-22.12.e1
  • Cosman F, de Beur S, LeBoff M, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359–2381. Erratum in: Osteoporos Int. 2015;26(7):2045–2047.25182228
  • Buckley L, Guyatt G, Fink HA, et al. American College of Rheumatology guideline for the prevention and treatment of gluco-corticoid-induced osteoporosis. Arthritis Care Res (Hoboken). 2017;69(8):1095–1110. doi:10.1002/acr.2295028585410

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.